Legal 500
  • Rankings

    • Jurisdictions

    • Submissions

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

  • Rankings

    • Jurisdictions

    • Submissions

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Data Protection policies
  • Cookies Policy
  • Supplier Code of Conduct
  • Modern Slavery and Human Trafficking Statement
  • Contact Us
  • Article

    Double Patenting In The EPO

    The issue of "double patenting" arises in the EPO when one applicant files two European patent applications with closely related claims and the same effective filing date.
    United KingdomIntellectual Property
    J A Kemp
    J A Kemp
  • Article

    How To Use Experimental Evidence In English Patent Litigation

    Experimental evidence can play a valuable role in patent litigation. It is not uncommon in patent validity proceedings for an expert will say to they would, when presented with a piece of prior art, ...
    United KingdomIntellectual Property
    J A Kemp
    J A Kemp
  • Article

    Problems In The Metaverse?

    For all the recent media hype, the "Metaverse" is still in the early stages of development. Once established, the metaverse will likely embody a shared, immersive, persistent virtual platform...
    United KingdomIntellectual Property
    J A Kemp
    J A Kemp
  • Article

    ChatGPT – The Future IP Advisor?

    What word comes next: Happy Birthday to ____? For most readers, the answer that springs to mind will be "You". But why did you think that was the answer?
    United StatesIntellectual Property
    J A Kemp
    J A Kemp
  • Article

    Introduction To Pharmaceutical Trade Marks

    A pharmaceutical trade mark is the same as any other trade mark in terms of the process for securing protection and the law governing the rights conferred on trade mark owners...
    United StatesIntellectual Property
    J A Kemp
    J A Kemp
  • Article

    UPC Exerts Long Arm Jurisdiction By Ruling On Infringement In UK

    In a landmark decision, the Unified Patent Court has ruled that it has jurisdiction over infringement actions concerning the UK part of a European patent, at least when the defendant is domiciled...
    United StatesIntellectual Property
    J A Kemp
    J A Kemp
  • Article

    CJEU Confirms Strict Interpretation Of Article 3(a) For SPCs

    On 30 April 2020 the CJEU gave its ruling in C-650/17 (Royalty Pharma).
    United KingdomIntellectual Property
    J A Kemp
    J A Kemp
  • Article

    IP Due Diligence

    Whatever the technology, IP can form a significant intangible asset for a company.
    United KingdomIntellectual Property
    J A Kemp
    J A Kemp
  • Article

    COP28 Series: Energy And Energy Efficiency

    Last year's 28th edition of the conference of the parties was notable for the pledge in the final draft of the agreement to "transition away" from fossil fuels.
    United StatesEnergy and Natural Resources
    J A Kemp
    J A Kemp
  • Article

    Paediatric Extensions To Supplementary Protection Certificates In The EU / EEA And UK

    Supplementary Protection Certificate (SPCs) for medicinal products are intellectual property rights intended to compensate patent holders for the loss in effective patent term that results from the time...
    European UnionIntellectual Property
    J A Kemp
    J A Kemp
  • Article

    Data Exclusivity And Market Protection In The EU / EEA And UK

    In order to place a new medicinal product on the market in Europe, it is necessary first to obtain a marketing authorisation.
    European UnionPrivacy
    J A Kemp
    J A Kemp
  • Article

    COP28 Series: Climate Change And Health, Non-Communicable Diseases (NCDs)

    According to the World Health Organization (WHO), non-communicable diseases (NCDs) kill 41 million people each year, which is equivalent to 74% of all deaths globally.
    United KingdomEnvironment
    J A Kemp
    J A Kemp
  • Article

    EPO Board Of Appeal Finds "No Legal Basis" For Requirement To Adapt The Description To Conform To The Claims

    Such amendments, whilst occasionally tedious, became an accepted part of practice at the EPO and had no noticeable impact on the scope of protection.
    United KingdomIntellectual Property
    J A Kemp
    J A Kemp
  • Article

    The Scope And Infringement Of Patents Claiming Strains Of Bacteria

    Understanding the scope of a patent claim is of utmost importance when assessing the strength and value of a portfolio and making appropriate commercial decisions, and when drafting new applications...
    United KingdomIntellectual Property
    J A Kemp
    J A Kemp
  • Article

    Third Party Intellectual Property

    A common misconception is that ownership of IP rights associated with a product gives an automatic right to make and sell that product.
    United KingdomIntellectual Property
    J A Kemp
    J A Kemp
  • Article

    IP Due Diligence

    Whatever the technology, IP can form a significant intangible asset for a company. In addition to legally protecting the company's products and activities from being copied by competitors...
    United StatesIntellectual Property
    J A Kemp
    J A Kemp
  • Article

    Protecting Your IP When Crowdfunding

    Crowdfunding can be a great way of raising funds. However, if you fund your business in this way you need to consider carefully how to protect your valuable intellectual property (IP).
    United StatesIntellectual Property
    J A Kemp
    J A Kemp
  • Article

    Patent Box - Patent Strategy Considerations

    The Patent Box makes the existence of a patent more attractive, whatever the breadth of the patent's claim, so long as it covers the product (or process or service).
    United KingdomIntellectual Property
    J A Kemp
    J A Kemp
  • Article

    EPO Enlarged Board Of Appeal Significantly Relaxes Formal Requirements For Making A Valid Priority Claim

    The EPO's Enlarged Board of Appeal has recently made a key ruling on the issue of priority entitlement in decision G1/22 and G2/22.
    United KingdomIntellectual Property
    J A Kemp
    J A Kemp
  • Article

    Marking Products As Patented In The UK

    In the UK, marking patented products as patented is not compulsory. However, there are several benefits to marking products as patented and both guidance from the UK Intellectual Property Office, and UK law...
    United StatesIntellectual Property
    J A Kemp
    J A Kemp

Showing 421–440 of 547 results

PreviousNext
Legal Intelligence Newsletters